THE PHARMACEUTICAL JOURNAL | Urinary tract infections are the second most common reason for prescribing an antibiotic and, with antimicrobial stewardship a growing priority around the world, the stakes for accurate diagnosis are being raised ever higher. Product developers, like CARB-X-funded Module Innovations, are racing to find better more efficient tools to diagnose drug-resistant UTIs more quickly, within hours rather than days, to facilitate appropriate treatment more quickly and potentially save lives.